An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Condition:   HypertensionInterventions:   Drug: Aliskiren;   Drug: EnalaprilSponsors:   Novartis;   Novartis PharmaceuticalsRecruiting - verified July 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2010 Category: Research Source Type: clinical trials

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Condition:   HypertensionInterventions:   Drug: Aliskiren;   Drug: EnalaprilSponsors:   Novartis;   Novartis PharmaceuticalsRecruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2010 Category: Research Source Type: clinical trials

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Condition:   HypertensionInterventions:   Drug: Aliskiren;   Drug: EnalaprilSponsors:   Novartis;   Novartis PharmaceuticalsRecruiting - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2010 Category: Research Source Type: clinical trials

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Condition:   HypertensionInterventions:   Drug: Aliskiren;   Drug: EnalaprilSponsors:   Novartis;   Novartis PharmaceuticalsRecruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2010 Category: Research Source Type: clinical trials

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Condition:   HypertensionInterventions:   Drug: Aliskiren;   Drug: EnalaprilSponsors:   Novartis;   Novartis PharmaceuticalsRecruiting - verified July 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2010 Category: Research Source Type: clinical trials

The Effect of Aliskiren on Endothelial Function in Pre-Diabetes and Diabetes
Condition:   Diabetes Type 2Interventions:   Drug: Placebo;   Drug: AliskirenSponsors:   Beth Israel Deaconess Medical Center;   Novartis PharmaceuticalsCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2009 Category: Research Source Type: clinical trials

Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients
Conditions:   Microalbuminuria;   Macroalbuminuric Diabetic Nephropathy;   Diabetes;   Proteinuria;   AlbuminuriaInterventions:   Drug: Aliskiren;   Drug: AliskirenSponsor:   John H. Stroger HospitalTerminated - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2009 Category: Research Source Type: clinical trials